Researchers at Longhua Hospital Shanghai University of Traditional Chinese Medicine Publish New Study Findings on Xenografts (Zhoushi Qi Ling decoction inhibits the progression of castration-resistant prostate cancer in vivo by regulating...).

A recent study conducted at Longhua Hospital Shanghai University of Traditional Chinese Medicine investigated the use of Zhoushi Qi Ling decoction (ZQD) in the treatment of castration-resistant prostate cancer (CRPC). The researchers found that ZQD treatment significantly reduced the progression of prostate cancer in a xenograft tumor mouse model. This was evidenced by a decrease in the number of infiltrated macrophages and the inhibition of the IL6/STAT3 signaling pathway. These findings suggest that ZQD may be a promising approach for the treatment of CRPC. [Extracted from the article]